Business Atlas

How Enterprise Is Built
Sign In
Text size
100%
Theme
Companies and Brands

Haleon plc

Health Care

Haleon plc is a British multinational consumer healthcare company headquartered in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins; it was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022.

Facts
Company Type
Public Limited Company 1
Founded Year
2022 1
Size Band
10,000 to 99,999 1
Listing
LSE 2
Status
Active 3
Company Type
Company Type (category)
Public 1
Company Type (category)
Limited Company 1
Connections

Operates In

Source Wikipedia, Haleon
Source Wikipedia, Haleon
In the Other Atlases

Located In

Also in Geography Atlas: where this subject is located.

Sources
1. Wikipedia, Haleon
Wikipedia
  • Infobox: num_employees
    24,000 (2024)
  • Infobox: type
    Public limited company
  • Lead section
    Haleon was established on 18 July 2022 as a corporate spin-off from GSK.
  • Operates In: Healthcare Industry, Infobox: industry
    Healthcare industry, Healthcare, Fast-moving consumer goods, Consumer goods
  • Operates In: Fast-Moving Consumer Goods Industry, Infobox: industry
    Healthcare industry, Healthcare, Fast-moving consumer goods, Consumer goods
View the Source
2. StockAnalysis.com: Haleon plc (LON:HLN) company profile
StockAnalysis.comProfile: quote header
Quote, Profile: quote header
Haleon plc (LON:HLN) United Kingdom · Delayed Price · Currency is GBP · Price in GBX
View the Source
3. StockAnalysis.com: StockAnalysis company profile for Haleon plc
StockAnalysis.com
  • Company profile: Stock Details
    Exchange NYSE
  • Company profile: price header
    Haleon plc (HLN) NYSE: HLN · Real-Time Price · USD
View the Source
Wikidata: Haleon plc
Wikidata Q112860932, class allow-list match (w-wdresolver-0926)View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.